Efficacy of high-dose olanzapine in a controlled fixed dose-response trial for the treatment of schizophrenia and schizoaffective disorder
Phase of Trial: Phase IV
Latest Information Update: 01 Aug 2008
At a glance
- Drugs Olanzapine (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 01 Aug 2008 Results have been published in the Journal of Clinical Psychopharmacology.
- 09 Oct 2005 New trial record.